Skip to main content

NASDAQ:RAPT Stock Forecast, Price Targets (Buy or Sell) | RAPT RAPT Therapeutics Analyst Ratings



Shared facilities with captive finance entities. When an issuer has a shared revolving credit facility with a captive finance entity, for purposes of calculating the issuer's liquidity sources, we net outstanding commercial paper at the captive from the revolver's borrowing availability. In these cases, we generally use an estimate of peak CP borrowings at the captive to avoid potentially overstating sources available to the issuer over a 12- to 24-month period.

We estimate RAPT RAPT Therapeutics stock forecast parameters by: Accumulation Distribution Line with Simple Regression



RAPT RAPT Therapeutics Stock Forecast (Buy or Sell) as of 18 Apr 2022 for (n+30)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Accumulation Distribution Line and Simple Regression. Machine Learning based stock forecast (n+30) for RAPT RAPT Therapeutics as below:

Time series to forecast n: 18 Apr 2022 for (n+30)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |